AWAK Attracts Investment Billions

Singapore-based AWAK Technologies’ miniaturized sorbent platform for PD and HD regenerates dialysate to use up to 90% less fluid. This package was intriguing enough to attract an $11.2B investment from Accuron MedTech—improving its changes of reaching the market!

Read the full article » | Posted 06-12-2017

Related Articles

• New Drug for Dialysis-related Itching Posted 11-12-2020
• Diality Raises $12.5M for its Portable Home HD System Posted 11-12-2020
• Quanta: a David to Dialysis Industry Goliaths Posted 10-12-2020
• Real-time Data-driven Dialysis Gets a Step Closer Posted 10-12-2020